LAVA Medtech Acquisition Corp. (LVAC) Stock
LAVA Medtech Acquisition Corp. (LVAC) currently lacks significant standalone operations.
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Latest News
Cash Flow (USD)
Valuation & Return Ratios
Peer Comparison
About LAVA Medtech Acquisition Corp.
LAVA Medtech Acquisition Corp. (LVAC) currently lacks significant standalone operations. Its primary objective is to secure businesses or assets through various strategic transactions, including mergers, capital stock exchanges, asset acquisitions, stock purchases, or corporate reorganizations. The firm's strategic focus is directed towards opportunities within the healthcare and allied industries. Established in 2021, the company is based in Waltham, Massachusetts, and operates as a subsidiary of LAVA Medtech Sponsor LP.
LAVA Medtech Acquisition Corp. is headquartered in US.
LAVA Medtech Acquisition Corp. (LVAC) stock trades at $10.43 with a market capitalization of $149.93M. The stock is valued at a price-to-earnings (P/E) ratio of 33.65, price-to-book of 1.29, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $9.94 and $10.85, and currently trades 3.9% below its 52-week high.
On profitability, LAVA Medtech Acquisition Corp. generates a return on equity (ROE) of 3.96%, return on capital employed of -1.35%, an operating margin of 0.00%, a net profit margin of 0.00%.